Evommune (EVMN) Shares Issued (2024 - 2025)
Evommune (EVMN) reported Shares Issued of $157.3 million for Q4 2025, up 1429700.0% year-over-year from N/an in Q4 2024, and up 1429700.0% on a QoQ basis from $11000.0 in Q4 2024.
Evommune (EVMN) has 2 years of Shares Issued data on file, last reported at $157.3 million in Q4 2025.
- Quarterly Shares Issued rose 1429700.0% year-over-year to $157.3 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $157.3 million (changed N/A YoY) and the FY2025 annual result came in at $157.3 million, up 1209776.92% from the prior year.
- Shares Issued climbed to $157.3 million in Q4 2025 per EVMN's latest filing, from $11000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $157.3 million in Q4 2025 and bottomed at $11000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Evommune | 744.11 Mn | 532.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 157.28 Mn |
| Dec 31, 2025 | 157.28 Mn |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |